A new national chlamydia sentinel surveillance system in Australia: evaluation of the first stage of implementation by Guy, Rebecca J. et al.
CDI Vol 34 No 3 2010 319
 Peer-reviewed articles
 Abstract 
 The Australian Collaboration for Chlamydia 
Enhanced Sentinel Surveillance (ACCESS) was 
established with funding from the Department 
of Health and Ageing to trial the monitoring of 
the uptake and outcome of chlamydia testing in 
Australia. ACCESS involved 6 separate networks; 
5 clinical networks involving sexual health services, 
family planning clinics, general practices, antenatal 
clinics, Aboriginal community controlled health 
services, and 1 laboratory network. The program ran 
from May 2007 to September 2010. An evaluation 
of ACCESS was undertaken in early 2010, 2 years 
after the program was funded. At the time of the 
evaluation, 76 of the 91 participating sites were 
contributing data. The jurisdictional distribution of 
the 76 sites generally matched the jurisdictional 
distribution of the Australian population. In 2008, 
the chlamydia testing rates in persons aged 
16–29 years attending the 26 general practices 
was 4.2% in males and 7.0% in females. At the 
25 sexual health services, the chlamydia testing 
rates in heterosexuals aged less than 25 years 
in 2008 was 77% in males and 74% in females. 
Between 2004 and 2008, the chlamydia positivity 
rate increased significantly in heterosexual females 
aged less than 25 years attending the sexual 
health services, from 11.5% to 14.1% ( P  < 0.01). 
Data completeness was above 85% for all core 
variables except Aboriginal and/or Torres Strait 
Islander status and country of birth, which ranged 
from 68%–100%, and 74%–100%, respectively, 
per network. There were delays in establishment 
of the system due to recruitment of 91 sites, 
multiple ethics applications and establishment of 
automated extraction programs in 10 different 
database systems, to transform clinic records into a 
common, pre-defined surveillance format. ACCESS 
has considerable potential as a mechanism toward 
supporting a better understanding of long-term 
trends in chlamydia notifications and to support 
policy and program delivery.  Commun Dis Intell 
2010;34(3):319–328. 
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 Introduction
 Th e primary role of public health surveillance is to 
guide the planning and evaluation of policy and 
programs, through the collection, analysis and 
interpretation of statistical information. In Aus-
tralia, the main form of chlamydia surveillance is 
passive reporting of cases to health departments 
by doctors or laboratories. 1  Passive surveillance 
has shown  Chlamydia trachomatis  to be the most 
commonly notifi ed infection in Australia with 
rates having risen nearly 4-fold in the past decade. 1 
 Passive surveillance has a natural appeal, in that it 
can be established on an ongoing basis, provides 
full geographic coverage and does not involve 
substantial programmatic expense. On the other 
hand, passive surveillance may be biased by testing 
patterns, as indicated by the strong correlation 
between the number of diagnoses and number of 
tests. 2–4  Also, notifi cation data do not routinely 
include information on characteristics such as 
gender of sex partner and in several jurisdictions 
are far from complete with regard to indigenous 
status. 5 
 A supplementary approach to surveillance is the 
use of selected clinical sites to collect systematic 
data on uptake and the outcome of chlamydia 
testing. Such data can be used to evaluate clinic-
based initiatives, broader prevention programs 
and help interpret trends in passive surveillance. 6,7 
 In May 2007 the Australian Government Depart-
ment of Health and Ageing (DoHA) funded the 
trialling of a new national sentinel surveillance 
system, entitled the Australian Collaboration 
for Chlamydia Enhanced Sentinel Surveillance 
(ACCESS) (www.access-study.org), based on 
5  networks of clinical sites and a laboratory 
network. Th is paper reports on an evaluation of 
this new system.
 A NEW NATIONAL CHLAMYDIA SENTINEL 
SURVEILLANCE SYSTEM IN AUSTRALIA: EVALUATION 
OF THE FIRST STAGE OF IMPLEMENTATION
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 Methods
 Th is evaluation of ACCESS was conducted from 
1 January to 31 March 2010 by project staff , using 
the framework promulgated by the US Centers for 
Disease Control and Prevention. 8  Specifi c goals 
were to:
1.  assess the simplicity, fl exibility, acceptability, 
timeliness, stability, validity, usefulness and 
representativeness of ACCESS;
2.  assess the data quality of the system by exami-
nation of the fi rst 12 months of data collection; 
and
3.  make recommendations to improve the system.
 For each ACCESS variable, completeness was the 
proportion of entries that were not missing or 
unknown. To determine representativeness, the 
proportion of ACCESS sites per jurisdiction was 
compared with the proportion of the population 
in the jurisdiction. Th e ratio of metropolitan 
and non-metropolitan ACCESS sites was also 
compared with this ratio for the Australian 
population. Population data were accessed from 
the 2006 Australian Bureau of Statistics data. 9  
Other surveillance attributes were assessed 
qualitatively through feedback from other 
ACCESS members and select partners, ACCESS 
meeting Minutes and quarterly progress reports 
submitted to DoHA.
 Results
 Description of ACCESS
 ACCESS was established as a collaboration 
between the National Centre in HIV 
Epidemiology and Clinical Research (NCHECR) 
and the Perinatal and Reproductive Epidemiology 
and Research Unit at the University of New 
South Wales (UNSW), the Burnet Institute’s 
Centre for Population Health, and the National 
Serology Reference Laboratory (NRL). UNSW 
(via NCHECR) and the Burnet Institute are 
jointly responsible for ACCESS. Other partners 
are the participating sentinel sites (Appendix), 
the National Aboriginal Community Controlled 
Health Organisation (NACCHO) and its state 
and territory based affi  liates; and DoHA as 
funding agency.
 Th e overall aim of ACCESS is to establish a 
sentinel surveillance system to evaluate the impact 
of interventions to control genital chlamydia 
infection. Specifi c objectives were to:
1.  establish 6 separate surveillance networks, each 
providing unique information on chlamydia 
testing;
2.  enhance the data management systems of 
sentinel sites with a view to routinely sending 
chlamydia surveillance data to a central 
location;
3.  monitor the extent of chlamydia testing at 
these sites;
4.  determine the chlamydia positivity in priority 
populations; including young heterosexuals 
(< 25 years), men who have sex with men 
(MSM), Aboriginal and/or Torres Strait 
Islander people, pregnant women and sex 
workers; and
5.  interpret trends determined by other chlamy-
dia surveillance mechanisms.
 ACCESS involves 5 clinical networks made 
up of sexual health services, family planning 
clinics, general practices, antenatal clinics and 
Aboriginal community controlled health services, 
and a laboratory network. Each network involves 
multiple sites, chosen under the following criteria 
(which varied by network):
1.  a specifi ed minimum number of chlamydia 
tests per year;
2.  geographic representation; and
3.  a minimum number of tests in priority popula-
tions specifi ed by the  National Sexually Trans-
missible Infections Strategy 2005–2008, 10  as 
defi ned in Table 1.
 On a quarterly or 6-monthly basis, a core set of 
data in de-identifi ed line-record format were 
extracted from sites (apart from the antenatal 
clinic network) and include patient demographic 
and chlamydia testing information. Additional 
information was collected from some specifi c 
networks; ‘gender of sexual partners’, ‘current sex 
work’, ‘sex overseas in the last 12 months’, ‘traveller 
or migrant status’ (sexual health service network), 
‘parity’ (antenatal clinic network) and specimen 
type (laboratory network). Extraction programs 
were developed to transform these records into a 
common, pre-defi ned format.
 Analyses were conducted of the proportion of 
patients tested for chlamydia and the proportion 
of those tested found to have infection (chlamydia 
positivity). Both were restricted to new or unique 
patients (those attending the clinic or tested for 
the fi rst time in the surveillance period). Analyses 
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for the sexual health service network were further 
broken down into heterosexuals aged less than 
25 years, MSM, Aboriginal and/or Torres Strait 
Islander people, and sex workers. Th e sexual health 
service network was able to compile retrospective 
data at the time of this evaluation. An analysis of 
time trends could be undertaken in the annual 
proportion of patients undergoing a chlamydia 
test on their fi rst visit and of chlamydia positivity 
over time. Signifi cance of the trend was assessed 
with a chi-squared test.
 Feasibility
 Feasibility was demonstrated by success in recruit-
ing and establishing sites. By the end of Febru-
ary 2010, 91 sentinel sites across 6 networks had 
agreed to participate in ACCESS, representing all 
jurisdictions in Australia (Table 2).
 Of the 91 sites, 76 (84%) provided data at the 
time of the evaluation (Table 3). Th e 5 clinical 
networks compiled information on about 90,000 
episodes of care in new patients and the laboratory 
network compiled information on about 40,000 
chlamydia tests, (which may have overlapped with 
the clinical networks).
 Feasibility was also demonstrated in the ability 
to estimate the proportion of patients tested for 
chlamydia and chlamydia positivity in a range of 
priority populations. In young men and women, 
the general practice network found that 4.2% of 
males and 7.0% of females aged 16–29 years who 
attended the 26 clinics, were tested and chlamydia 
positivity was 9.9% and 7.0% respectively. In the 
sexual health service network, 77% of males and 
74% of females aged less than 25 years were tested 
in the same period and positivity was 9.5% and 
9.1%, respectively. Th e overall chlamydia positiv-
ity rate was 7.0% among pregnant women aged 
16–24 years in the antenatal network.
 In the laboratory network, the chlamydia positiv-
ity estimate was 6.2% in rectal swabs collected 
 Table 1:  Priority populations seen at ACCESS network sites 
Network Priority populations 
Sexual health service network Young men and women (<25 years), men who have sex with men, Aboriginal and/or 
Torres Strait Islander people, and sex workers
Family planning clinic network Young women and men aged 16–29 years
Antenatal clinic network Young pregnant women aged 16–24 years including Aboriginal and/or Torres Strait 
Islander people 
Aboriginal community controlled 
health service network
Aboriginal and/or Torres Strait Islander people aged 16–39 years
General practice network Young women and men aged 16–29 years
Laboratory network All individuals tested for chlamydia 





GP FPC SHS ANC ACCHS Lab All
n % n n n n n n n %
ACT 339,865 1.6 0 1 1 1 0 0 3 3.3
 NSW 6,889,072 32.8 5 1 15 1 2 3 27 29.7
NT 214,975 1.0 0 1 2 1 1 0 5 5.5
Qld 4,182,062 19.9 6 1 4 1 2 4 18 19.8
SA 1,584,513 7.5 4 1 0 0 0 2 7 7.7
Tas 493,341 2.3 2 1 1 0 0 1 5 5.5
Vic 5,205,216 24.8 8 1 1 4 1 5 20 22.0
WA 2,105,783 10.0 2 1 1 1 1 0 6 6.6
Aust 21,017,222 100 27 8 25 9 7 15 91 100.0
 
 GP=General practice, FPC=Family planning clinic, SHS=Sexual health service, ANC=Antenatal clinic, 
ACCHS=Aboriginal community controlled health service, Lab=Laboratory 
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in men who were most likely to be MSM. In the 
sexual health service network, chlamydia positiv-
ity was 7.2% in MSM.
 Th e feasibility of reporting time trends was dem-
onstrated through the sexual health network. 
Between 2004 and 2008 at 19 sexual health serv-
ices the annual proportion of patients tested for 
chlamydia on their fi rst visit increased signifi cantly 
for all priority populations,  P <0.001 (Table 4) and 
chlamydia positivity increased signifi cantly in het-
erosexual females from 11.5% to 14.1%,  P  < 0.001 
(Figure), but not other populations.
 Simplicity
 Th e automatic collation of routine clinical data 
from the network sites, apart from antenatal 
clinics, refl ects simplicity. Th e 2 key outcomes are 
relatively straightforward to calculate from the 
variables compiled. Also, although not formally 
assessed, the ACCESS system is likely to be very 
much cheaper than repeated community surveys 
of this magnitude.
 On the other hand, initiation of 91 sentinel sites 
was complex because of the multiple ethics appli-
cations required, and the range of patient man-
agement systems used at these sites. Th e antenatal 
clinic network used a model that diff ers from 
other networks, because underlying testing rates 





GP FPC SHS ANC ACCHS Lab All
n % n n n n n n n %
ACT 339,865 1.6 0 1 1 1 0 0 3 3.9
N SW 6,889,072 32.8 4 1 15 1 0 0 21 27.6
NT 214,975 1.0 0 1 2 1 0 0 4 5.3
Qld 4,182,062 19.9 6 0 4 1 2 3 16 21.1
SA 1,584,513 7.5 4 1 0 0 0 0 5 6.6
Tas 493,341 2.3 2 1 1 0 0 0 4 5.3
Vic 5,205,216 24.8 8 1 1 4 1 3 18 23.7
WA 2,105,783 10.0 2 0 1 1 1 0 5 6.6
Aust 21,017,222 100 26 6 25 9 4 6 76 100.0
 
 GP=General practice, FPC=Family planning clinic, SHS=Sexual health service, ANC=Antenatal clinic, 
ACCHS=Aboriginal community controlled health service, Lab=Laboratory 
 Table 4:  Chlamydia testing rates among new patients at the 19 sexual health services in 











Young heterosexuals < 25 years 60.9 64.9 67.5 70 71.1
Men who have sex with men 74.8 77.3 78.9 80.9 78.0
Aboriginal and/or Torres Strait Islanders 48.9 49.5 54.6 55.8 53.0
Sex workers 60.9 64.9 67.5 70.0 71.1
 
 The population breakdowns are not exclusive and individuals may be present in more than 1 priority population 
 Figure:  Chlamydia positivity among new 
heterosexual patients (<25 years) at the 19 
sexual health services in ACCESS, 2004 to 
































Young heterosexual  males <25 years
Young heterosexual  females <25 years
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were low in this setting. Accordingly, the network 
introduced chlamydia testing for consecutively 
recruited women aged 16–24 years, based on 
written consent, which substantially increased the 
human resources required to carry out the study. 
Th e recent increase in birth rates put further pres-
sure on antenatal clinics participating in ACCESS.
 Representativeness
 Across networks, the jurisdictional distribution of 
the 76 operational sites generally matched the dis-
tribution of the Australian population (Table 2). 
For example, the proportion of sites in New South 
Wales, Victoria and Queensland were 28%, 24% 
and 21%, compared with the proportion of the 
resident population in these jurisdictions of 33%, 
25%, 20% respectively (Table 2).
 Th e correspondence was poorer within networks, 
with only 2 jurisdictions represented in the labora-
tory network, four in the ACCHS network and 
fi ve in the family planning and general practice 
networks (Table 2).
 Overall, 70% of the operational sites were located 
in metropolitan areas, 28% in regional areas and 
3% in remote areas (Table 5), which is similar 
to the distribution of the resident population in 
Australia of 66%, 31% and 3%, respectively. 13 
 Flexibility
 Health surveillance system can adapt to chang-
ing information needs or operation conditions 
with little additional time, personnel, or allocated 
funds. 11  Apart from the antenatal clinic network, 
ACCESS was based on collection of routine clini-
cal data, so as long as any additional information 
is systematically recorded in the patient manage-
ment system by sites, ACCESS has the capacity to 
be modifi ed relatively easily including collection 
of data on additional infections such as syphilis, 
gonorrhea and HIV.
 Timeliness
 Th e ACCESS system has not been operational 
long enough to demonstrate whether or not its 
outputs are suffi  ciently timely to support public 
health programs and policy. However, all of the 
networks (except the antenatal clinic network) 
are now in a position to undertake regular data 
collection automatically, and generate reports 
3–6 months after the end of each calendar year. 
Given that sexually transmitted infections (STIs) 
do not generally require an acute public health 
response, this time frame should respond well to 
the needs of program planning and evaluation.
 Sustainability
 Th e key feature of ACCESS is that it utilises rou-
tinely collected data from clinical and laboratory 
settings. Th erefore as long as staffi  ng is available 
for analysis and reporting, the system will be 
sustainable.
 Acceptability
 Acceptability is refl ected by the willingness of 
persons and organisations to participate in the 
surveillance system. 11  Th e entire premise of 
ACCESS was to establish data collection systems 
that operate automatically and have no impact 
on routine clinical operations. Each network was 
overseen by a steering committee that includes 
representation from sites to ensure that operations 
are acceptable to the clinicians and data managers 
at the sites. No participating sites withdrew from 
participating once they became operational. One 
general practice site recently became ineligible due 
to changing to a patient management system not 
 Ta ble 5:  Location of operational sentinel sites in the 5 clinical networks, 1 March 2010 
Clinical network Location of sentinel site
Metropolitan Regional Rural Total
n % n % n % n %
GP 19 73.1 7 26.9 0 0.0 26 100
FPC 5 100.0 0 0.0 0 0.0 5 100
SHS 16 64.0 8 32.0 1 4.0 25 100
ANC 7 77.8 1 11.1 1 11.1 9 100
ACCHS 1 25.0 3 75.0 0 0.0 4 100
All 48 69.6 19 27.5 2 2.9 69 100
 
 The laboratory network was not included as most laboratories service all areas. 
 GP=General practice, FPC=Family planning clinic, SHS=Sexual health service, ANC=Antenatal clinic, 
ACCHS=Aboriginal community controlled health service 
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compatible with the extraction program, but was 
interested in  participating in the future if ACCESS 
was able to develop a compatible interface.
 Data quality
 Overall, the completeness of the data from ACCESS 
sites was excellent, and for most variables, exceeded 
the recommendation of 85% in the CDC surveil-
lance standards. 12  Th e exceptions were Aboriginal 
and/or Torres Strait Islander status and country 
of birth, which ranged from 68%–100%, and 
76%–100%, respectively, per network. Aboriginal 
and Torres Strait Islander status was 95% complete 
in the 25 sexual health services who provided data 
at the time of the evaluation, 86% complete in the 
4 Aboriginal community controlled health services 
and 68% in the general practice and family plan-
ning clinic networks. In the family planning clinic 
network the ‘country of birth’ variable had a 76% 
completion rate.
 Validity
 Th ere are several ways in which validity might be 
assessed. At a basic level of reporting accuracy, 
the performance of the software used to iden-
tify chlamydia tests in the patient management 
systems of 3 clinics in the general practice network 
can be compared with testing data from the same 
clinics, collated directly from laboratory services 
participating in a separate Victorian surveillance 
project. 13  When linked to version 2 of Medical 
Director as used by 1 clinic, the ACCESS report-
ing software detected 84% of the chlamydia tests 
reported by the laboratories, and the sensitivity 
increased to 97% at the other 2 clinics, which used 
version 3 of Medical Director. Conversely all of 
the tests detected via the ACCESS software were 
identifi ed in the Victorian surveillance dataset 
(specifi city).
 Th e validity of the system was also supported by 
the stability of the reported profi le of patients 
attending the participating clinics. At the 
19 sexual health services, annual numbers of new 
patients remained quite steady (between 21,929 
and 23,267). Th e median age was 28 years from 
2004 to 2005 then 27 years from 2007 to 2008.
 Sensitivity
 Sensitivity is generally quantifi ed as the propor-
tion of cases of a disease or health event that are 
detected by a surveillance system. 12  ACCESS does 
not aim to capture all chlamydia diagnoses in 
Australia but instead focuses on priority popula-
tions attending clinical sites, and monitors testing 
uptake and chlamydia positivity in these groups. 
In this context, the main factor that could have 
an impact on sensitivity is under-reporting. As 
noted above under validity, ACCESS data extrac-
tions rely on the test and result being recognis-
able and extractable in the patient management 
system, and appear to have high sensitivity when 
compared with an alternative data source in the 
general practice network.
 Usefulness
 Th e sexual health service network has provided 
some important data on time trends, as described 
under feasibility. Th ese fi ndings suggest that the 
steadily increasing chlamydia diagnoses observed 
through passive surveillance in recent years in 
Australia may refl ect a true increase in chlamydia 
incidence in Australia. In the long term, outcomes 
from other networks will be important to inter-
pret alongside those observed in the sexual health 
service network. Another important fi nding from 
the sexual health service network and laboratory 
network was the chlamydia positivity estimates in 
MSM, based on testing of rectal swabs in men.
 Discussion
 Th e fi rst 2 years of ACCESS demonstrated that it 
is possible to establish a national network of diverse 
clinical and laboratory sites for the purpose of col-
lecting, analysing and reporting standardised data 
on the uptake and outcome of testing for chlamy-
dia. ACCESS has also demonstrated that clinical 
services can routinely compile information on 
chlamydia positivity in large numbers of patients. 
Although alternative models were not costed, it is 
likely that ACCESS costs a fraction of what would 
be required to conduct repeated surveys among 
the priority populations.
 Th e evaluation led to 6 main recommendations 
about how the operation of ACCESS could be 
improved (Box).
 As shown in other countries, systems similar to 
ACCESS can help to interpret trends in chlamy-
dia passive surveillance. 7,14–17  Data from the 
sexual health network indicated a 23% increase 
in chlamydia positivity in young heterosexual 
women between 2004 and 2008, in contrast to 
the much sharper rise in case counts reported 
from passive surveillance in the same time period, 
suggesting some of the increase in case counts is 
likely to be related to increased testing.
 For populations such as MSM who undergo 
frequent testing for Chlamydia, the sexual health 
service network will be able to provide national 
incidence estimates, that have previously only been 
available from single study cohorts. 18  Incidence is 
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the most sensitive indicator of changes in disease 
transmission, but is very expensive to assess 
through prospective cohorts. Line-listed records, 
linked by unique personal identifi ers and informa-
tion related to serial consultations can be used to 
provide incidence data. 19 
 Although the system has been developed for 
monitoring chlamydia, its design is such that it 
could easily be adapted to the monitoring of other 
treatable bacterial STIs, such as syphilis and gon-
orrhea, or viral STIs such as HIV. Th e marginal 
cost of expanding the surveillance system to other 
infection would be far less than the cost of start-
ing new systems for each of these infections.
 ACCESS provided information on some variables 
not available through national chlamydia passive 
surveillance, in particular the sex of sexual partner, 
which allows trends to be analysed separately for 
MSM and heterosexual populations. As with 
passive surveillance, completeness in ACCESS was 
poorest for Aboriginal and Torres Strait Islander 
status, but ACCESS did achieve somewhat higher 
completeness rates for this variable than passive 
surveillance in New South Wales, Queensland, 
the Australian Capital Territory and Tasmania. 5 
 Th e evaluation found that ACCESS sites were 
represented in all jurisdictions. Th e general practice 
network could be further expanded to increase the 
capacity of jurisdictions to evaluate local testing 
initiatives. In the longer term, data collected 
through ACCESS, particularly the general practice 
network, would also be able to provide pre– and 
post-descriptions of clinical populations, as a basis 
for evaluating new programs. Another applica-
tion of ACCESS data would be the assessment of 
compliance with clinical testing guidelines. 20  Th e 
laboratory network also provides a very large sample 
size to ensure very robust chlamydia positivity rate 
estimates and in the long term will provide impor-
tant population level testing data, covering both the 
public and private laboratory sectors.
 ACCESS would also be able to provide valu-
able information about testing and chlamydia 
positivity rates in Aboriginal and/or Torres Strait 
Islander people attending a variety of clinical 
services in urban, regional and remote areas in 
Australia. Currently, the limited available data 
about STI testing undertaken by health services 
in Aboriginal and Torres Strait Island people are 
biased toward remote and regional settings. 21–23  
Also because health departments in New South 
Wales and Queensland, with substantial Aborigi-
nal populations, rely on laboratory notifi cations, 
the results of passive STI surveillance cannot be 
used to describe the STI epidemiology in this 
population. 5  A clearer picture may emerge if there 
was expansion of the Aboriginal community con-
trolled health service network over the long term, 
particularly in New South Wales and Queensland. 
Any future directions of this network are subject 
to community consultation.
 Th e antenatal clinic network methodology proved 
much more expensive and complex to implement 
because chlamydia testing is not routine in that 
setting. Nevertheless, this network has netted 
invaluable data on the prevalence of chlamydia 
in pregnant women in Australia. It is anticipated 
 Box:  Key evaluation recommendations for the ACCESS system 
1.  Each network should undertake validity studies along the lines of those conducted by the 
general practice network; 
2.  ACCESS fi ndings should be disseminated widely, to ensure that all relevant stakeholders can 
use them to plan and evaluate interventions related to chlamydia testing; 
3.  Th e general practice network should be enhanced by the addition of more sites in certain juris-
dictions and expanded to a much larger number of clinics over the long-term; 
4.  Subject to community consultation, the  Aboriginal community controlled service network 
should be expanded to include more sites over the long term, particularly in New South Wales 
and Queensland. 
5.  A less resource-intensive surveillance system should be used for antenatal services such as the 
model used in other networks of ACCESS; 
6.  Th e collection of information on other sexually transmissible infections such as syphilis and 
gonorrhoea should be considered. 
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that antenatal chlamydia testing will increase in 
the future, so the model used in other ACCESS 
networks could provide a less resource-intensive 
surveillance system for antenatal services.
 Th ere is no perfect surveillance mechanism for 
monitoring the prevalence of infections such as 
chlamydia in populations. Surveys of the whole 
population are inevitably subject to bias because 
of incomplete participation, and surveys that aim 
to recruit particular population groups inevitably 
rely on sampling frames that can not truly replicate 
the membership of these groups. Th e approach 
adopted by ACCESS is to monitor chlamydia 
positivity rates, as a surrogate for prevalence, in 
patients attending specialised clinical services. Th is 
approach has similar limitations to the population 
surveys, in that it is unknown how representative 
these patients are of any wider group from which 
they are drawn. Chlamydia positivity rates may 
be infl uenced by the proportion and nature 
of the patients being tested. Some groups may 
undergo testing at particular times in response to 
campaigns, or clinics may change testing policies 
resulting in more asymptomatic patients being 
tested. Th e restriction of the analysis to new 
patients (or those testing for the fi rst time in the 
surveillance period) was intended to reduce the 
impact of this potential bias and provide accurate 
chlamydia positivity for surveillance purposes.
 Passive notifi cation data demonstrated that 
chlamydia diagnoses have increased sharply 
over the past decade in Australia. ACCESS has 
the potential to complement this observation 
by providing a systematic means of measuring 
any changes in testing levels by specifi c priority 
populations and monitoring trends in chlamydia 
positivity in these groups, thereby enhancing our 
capacity to respond to and control this infection.
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 Appendix: Participating ACCESS sites
 Note: some participating sites preferred not to be 
named in this paper
 Sexual health service network
 Hunter New England Sexual Health Service; NSW
 Sydney West Area Health Service – Clinical Sexual 
Health Services; NSW
 Illawarra Sexual Health, Wollongong; NSW
 Royal Prince Alfred Hospital Sexual Health, 
Camperdown; NSW
 Holden Street Clinic, Gosford; NSW
 Lismore/ Tweed Heads Sexual Health & AIDS 
Services, Lismore; NSW
 Northern Sydney Sexual Health Service, 
St Leonards; NSW
 Greater Southern Area Health Service; NSW
 Orange Sexual Health Service, Orange; NSW
 Kirketon Road Centre, Darlinghurst; NSW
 Sydney Sexual Health Centre, Sydney; NSW
 Short Street Sexual Health Clinic, NSW
 St George Hospital, St George; NSW
 Coffs Harbour Sexual Health Service, Coffs 
Harbour; NSW
 Grafton Sexual Health Clinic, Grafton; NSW
 Gold Coast Sexual Health Clinic, Miami; Qld
 Cairns Sexual Health Services, Cairns Base 
Hospital, Cairns; Qld
 Princess Alexandra Sexual Health, Princess 
Alexandra Hospital, Woolloongabba, Qld
 Townsville Sexual Health Service, Townsville, Qld
 Melbourne Sexual Health Centre, Carlton, Vic
 Hobart, Devonport and Launceston Sexual Health 
Service, Tas
 Fremantle Hospital, Fremantle, WA
 NT Sexual Health and BBV Unit, NT
 Family planning clinic network
 Sexual Health and Family Planning, ACT,
 Newcastle FPNSW Centre, Cooks Hill, NSW
 Family Planning NT, Coconut Grove, NT
 Family Planning Queensland, Toowoomba, Qld
 Shine SA (Sexual Health information networking 
and education Inc), SA
 Family Planning Tasmania, Hobart, Tas
 Family Planning Victoria, (Action Centre), 
Melbourne, Vic
 Quarry Health Centre for under 25s, Fremantle, WA
 General practice clinic network
 Charlestown Family Medical Services, 
Charlestown, NSW
 Midway Family Medical Centre, Denistone East, NSW
 Glendale Medical Centre, Glendale, NSW
 Young District Medical Centre, Young, NSW
 Brindabella Family Practice, Queanbeyan, NSW
 Angaston Medical Centre, Angaston, SA
 Genesis Medical Centre, Brighton, Vic
 Footscray Medical Centre, Footscray , Vic
 Goulburn River Group Practice, Seymour, Vic
 Wellness Centre Medical Clinic, Malvern East, Vic
 Brighton Medical Clinic, Brighton, Vic
 Mooroopna Medical Centre, Mooroopna, Vic
 Duncraig Medical Centre, Duncraig , WA
 AK medical/dental Clinic, Kelmscott, WA
 Chancellor Park Family Medical Practice, Sippy 
Downs, Qld
 Nambour Medical Centre, Nambour, Qld
 Eli Waters Medical Centre, Eli Waters, Qld
 Yeppoon Family Practice, Yeppoon , Qld
 Kewarra Family Practice, Kewarra Beach, Qld
 Turton St Medical Centre, Sunnybank, Qld
 O’Brien Street Practice, Adelaide, SA
 Davey Street Medical Centre , Hobart, Tas
 Newstead Medical, Launceston, Tas
 Duncraig Medical Centre, Duncraig, WA
 Brighton Medical Clinic, Brighton, Vic
 North Sydney Medical Practice, North Sydney, NSW
 Centre Clinic, St Kilda, Vic
 Aboriginal community controlled health 
service network
 Aboriginal Medical Service Western Sydney, 
Mount Druitt Village, NSW
 Durri Aboriginal Corporation Medical Service, 
Kempsey, NSW
 Victorian Aboriginal Health Service, Fitzroy, Vic
 Geraldton Regional Aboriginal Medical Service, 
Geraldton, WA
 Danila Dilba Health Service, Darwin, NT
 Carbal Medical Service, Toowoomba, Qld 
 Goondir Health Service, Dalby, Qld
 
